Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
Makes respiratory devices and masks for hospitals and home sleep apnea treatment.
34.67+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+5.4%
The outlook
Fisher & Paykel Healthcare is trading near the top of its 52-week range, well above its key moving averages, with analyst consensus favoring a Buy rating. The average price target sits about 5% above the current level, though the stock carries a notably elevated trailing P/E of 52.5, reflecting investor expectations for future growth.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 9 analysts
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 9 analysts36.56average target+5.5% vs now
Now 34.67
Low 25.49High 43.02
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$20.36B
52-wk high
35.31
52-wk low
26.51
50-day avg
31.63
200-day avg
31.88
Trailing P/E
52.5